Alert

Recommended Alerts

Sign Up For Alerts

USPTO Director Issues Interim Guidance on Discretionary Denials of PTAB Petitions

On June 21, 2022, U.S. Patent and Trademark Office (USPTO) Director Katherine K. Vidal issued new, binding interim guidance addressing the Patent Trial and Appeal Board’s (PTAB) approach to discretionary denials of PTAB petitions.

Read More

Woglom to address London pharmaceutical patent conference


Time to Read: 1 minutes Practices: Intellectual Property

Eric C. Woglom, a partner in the Fish & Neave IP Group of Ropes & Gray, will discuss recent legislative and judicial developments affecting the U.S. pharmaceutical industry, including the status of proposed patent law reform measures, at the fifth annual Pharmaceutical Patent Life Cycles Conference in London on January 19-20, 2006.

Presented by C5, the conference provides authoritative information on strategies and developments in the field of pharmaceutical patents to a large audience of in-house and patent counsel, attorneys, patent agents and directors and managers of IP from pharmaceutical companies worldwide.

Cookie Settings